Crossmark

Impact on fluid balance of an optimized restrictive strategy targeting non-resuscitative fluids in intensive care patients with septic shock: a single-blind, multicenter, randomized, controlled, pilot study

Crossref DOI link: https://doi.org/10.1186/s13054-024-05155-z

Published Online: 2024-12-21

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Boulet, Nicolas

Quenot, Jean-Pierre

Serrand, Chris

Antier, Nadiejda

Garnier, Sylvain

Buzancais, Aurèle

Muller, Laurent

Roger, Claire

Lefrant, Jean-Yves

Barbar, Saber Davide
Clinical Trials ^BETA

Clinical trials referenced in this document:

nct04947904 at ClinicalTrials.gov

Documents that mention this clinical trial

Impact on fluid balance of an optimized restrictive strategy targeting non-resuscitative fluids in intensive care patients with septic shock: a single-blind, multicenter, randomized, controlled, pilot study
https://doi.org/10.1186/s13054-024-05155-z
License Information

Text and Data Mining valid from 2024-12-21

Version of Record valid from 2024-12-21
More Information

Article History

Received: 10 September 2024

Accepted: 31 October 2024

First Online: 21 December 2024

Declarations

:

: The study was approved by the Comité de Protection des Personnes Sud-Méditerranée II (Number 2020-A01952-37). Written informed consent was obtained from patients or their legal surrogates.

: Written informed consent was obtained from patients or their legal surrogates either before randomization or as soon as possible thereafter.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below